Outcomes of the TOPIC extension study of teriflunomide in patients with early multiple sclerosis: Up to 7 years of clinical results

Authors
Category Primary study
ConferenceMultiple Sclerosis
Year 2016
This article has no abstract
Epistemonikos ID: 6b4ba8b186bc72e65f80ea5508e4aaf46c6cac36
First added on: Apr 29, 2026